A case of scurvy associated with nilotinib.

Oak, Allen S W; Jaleel, Tarannum; Fening, Katherine; Pavlidakey, Peter G; Sami, Naveed

Oak, Allen S W; Jaleel, Tarannum; Fening, Katherine; Pavlidakey, Peter G; Sami, Naveed.

Afiliação

Oak AS; Department of Dermatology, University of Alabama at Birmingham, Birmingham, AL, USA.
Jaleel T; Department of Dermatology, University of Alabama at Birmingham, Birmingham, AL, USA.
Fening K; Department of Dermatology, University of Alabama at Birmingham, Birmingham, AL, USA.
Pavlidakey PG; Department of Dermatology, University of Alabama at Birmingham, Birmingham, AL, USA.
Sami N; Department of Dermatology, University of Alabama at Birmingham, Birmingham, AL, USA. nsami@uabmc.edu.

J Cutan Pathol ; 43(8): 725-6, 2016 Aug.

Article em En | MEDLINE | ID: mdl-27124705

Assuntos

Antineoplásicos/efeitos adversos; Ceratose/etiologia; Pirimidinas/efeitos adversos; Escorbuto/induzido quimicamente; Idoso; Humanos; Leucemia Mielogênica Crônica BCR-ABL Positiva/tratamento farmacológico; Masculino; Escorbuto/patologia

Palavras-chave

Nilotinib; chronic myelogenous leukemia; scurvy; tyrosine kinase inhibitor

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirimidinas / Escorbuto / Ceratose / Antineoplásicos Tipo de estudo: Risk_factors_studies Limite: Aged / Humans / Male Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google